Amgen, Inc. (AMGN)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

ONE AMGEN CENTER DRIVE THOUSAND OAKS, CA 91320

Amgen Inc. (Amgen) is an independent biotechnology medicines company. The Company discovers, develops, manufactures and markets medicines for grievous illnesses. It focuses on human therapeutics and concentrates on medicines based on advances in cellular and molecular biology. Its principal products include Aranesp (darbepoetin alfa) and EPOGEN (Epoetin alfa), erythropoietic-stimulating agents (ESAs) that stimulate the production of red blood cells; Neulasta (pegfilgrastim), a pegylated protein, based on the Filgrastim molecule, and NEUPOGEN (Filgrastim), a recombinant-methionyl human granulocyte colony-stimulating factor (G-CSF), both of which selectively stimulate the production of neutrophils (a type of white blood cell that helps the body fight infection), and Enbrel (etanercept), an inhibitor of tumor necrosis factor (TNF), a substance that plays a role in the body's response to inflammatory diseases.

Data based on most recent fiscal year report
Market Cap122.113 Billion Shares Outstanding725.91 Million Avg Volume5.617 Million
1-Yr BETA vs S&P TR Current Ratio5.49 Quick Ratio5.17
View SEC Filings from AMGN instead.
Q3 2019 All Institutions Hedge Funds 1
To trade AMGN now:
Filers who had this stock in their top 10: 61 5 (0.52%)
13F Filers holding this stock: 1788 120 (12.54%)
Aggregate 13F shares on 09/30/2019: 450.968 Million 18.312 Million
Aggregate 13F shares on 06/30/2019: 457.546 Million 20.098 Million
Percent change: -1.44% -8.88%
Funds creating new positions: 111 12
Funds Adding to an existing position: 688 40
Funds closing out their position: 76 8
Funds reducing their position: 742 54
Heat Map Ranking for 09/30/2019 126
Heat Map Ranking for 06/30/2019 108
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding AMGN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

4.4 Thousand total shares from 3 transactions

Exercise Derivative Conversion (M)

4 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SUGAR RONALD D

203,643 2019-11-08 11

WILLIAMS R SANDERS

  • Director
5,413 2019-11-06 3

GORDON MURDO EVP GLOBAL COMMERCIAL OPS

  • Officer
34,024 2019-11-02 2

GRAHAM JONATHAN P EVP, GEN. COUNSEL & SECY.

  • Officer
51,853 2019-11-01 6

KULLMAN ELLEN JAMISON

  • Director
5,335 2019-11-01 4

JOHNSTON LORI A EVP, HR

  • Officer
26,457 2019-11-01 4

HOLLEY CHARLES M

  • Director
576 2019-11-01 4

JACKS TYLER

  • Director
6,411 2019-10-25 2

AUSTIN WANDA M

  • Director
0 2019-10-25 1

BALTIMORE DAVID

  • Director
0 2019-10-10 0

HERRINGER FRANK C

  • Director
0 2019-10-01 1

BRADWAY ROBERT A

  • Director
0 2019-10-01 5

BIONDI FRANK

  • Director
9,400 2019-09-04 0

PATTON CYNTHIA M SVP & CCO

  • Officer
22,361 2019-08-30 7

BALACHANDRAN MADHAVAN

  • Director
12,111 2019-08-22 0

HENDERSON REBECCA M

  • Director
14,696 2019-08-14 1

GARLAND GREG C. CHAIRMAN AND CEO

  • Officer
  • Director
463,041 2019-08-05 1

SANTOS ESTEBAN EVP, OPERATIONS

  • Officer
38,177 2019-08-01 7

TROSS STUART A CHIEF PEOPLE & WORKPL OFFICER

  • Officer
121,785 2019-07-31 0

ECKERT ROBERT

  • Director
129,227 2019-06-20 1

GLUCK FREDERICK W

  • Director
0 2019-06-19 0

SCHAEFFER LEONARD D

  • Director
0 2019-06-18 0

BEIER DAVID W

  • Director
0 2019-06-13 0

OMENN GILBERT S

  • Director
66,769 2019-05-31 0

MORROW GEORGE J

  • Director
0 2019-05-22 0

PEACOCK JONATHAN M

  • Director
142,001 2019-05-21 0

PERLMUTTER ROGER M EXE V-P & PRES, MRL

  • Officer
176,357 2019-05-03 0

PIACQUAD DAVID SVP, BUSINESS DEVELOPMENT

  • Officer
47,555 2019-05-03 6

MELINE DAVID W EVP & CFO

  • Officer
57,903 2019-05-03 6

HASSAN FRED

  • Director
8,345 2019-05-03 1

DRUKER BRIAN

  • Director
1,819 2019-05-03 1

REESE DAVID M EVP, RESEARCH AND DEVELOPMENT

  • Officer
36,075 2019-05-03 5

COFFMAN VANCE D

  • Director
24,486 2019-03-06 0

PELHAM JUDITH C

  • Director
13,588 2019-02-07 0

HARPER SEAN E EVP, RESEARCH & DEVELOPMENT

  • Officer
56,082 2018-07-16 0

HOOPER ANTHONY C EVP, GLOBAL COMMERCIAL OPS.

  • Officer
215,147 2018-05-03 0

DE CARBONNEL FRANCOIS

  • Director
16,426 2018-04-27 0

BONANNI FABRIZIO

  • Director
0 2017-06-19 0

MCNAMEE BRIAN M EVP

  • Officer
102,516 2017-05-01 0

SUCH ANNETTE LOUISE VP, FINANCE AND CAO

  • Officer
8,478 2017-05-01 0

CHOATE JERRY D

  • Director
No longer subject to file 2016-05-12 0

SCOTT DAVID J SVP, GEN. COUNSEL & SECY.

  • Officer
93,949 2015-04-25 0

SHARER KEVIN W

  • Director
42,344 2015-03-31 0

MICHAEL A KELLY ACTING CFO

  • Officer
39,361 2014-06-30 0

DITTRICH THOMAS J.W. VP, FINANCE & CAO

  • Officer
18,589 2014-05-21 0

REASON J PAUL

  • Director
25,520 2013-04-26 0

RICHO ANNA SVP & CCO

  • Officer
49,465 2012-08-01 0

FLANAGAN THOMAS JAMES SR VP & CIO

  • Officer
41,826 2010-12-08 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

SUGAR RONALD D - Director

2019-11-06 M 2,000 d 0 14,436.00 direct

WILLIAMS R SANDERS - Director

2019-11-06 S 425 $215.45 d 5,413 5,413.00 direct

SUGAR RONALD D - Director

2019-11-06 S 2,000 $215.45 d 14,436 14,436.00 direct

SUGAR RONALD D - Director

2019-11-06 M 2,000 $54.71 a 16,436 14,436.00 direct

GORDON MURDO - Officer EVP GLOBAL COMMERCIAL OPS

2019-11-02 F 5,812 $217.95 d 34,024 34,024.00 direct

JOHNSTON LORI A - Officer EVP, HR

2019-11-01 A 7,799 a 26,457 26,457.00 direct

HOLLEY CHARLES M - Director

2019-11-01 A 153 a 3,073 4,333.00 direct

GRAHAM JONATHAN P - Officer EVP, GEN. COUNSEL & SECY.

2019-11-01 A 9,176 a 51,853 51,853.00 direct

KULLMAN ELLEN JAMISON - Director

2019-11-01 A 261 a 5,335 5,335.00 direct

SUGAR RONALD D - Director

2019-10-02 M 2,000 $54.71 a 16,436 14,436.00 direct

SUGAR RONALD D - Director

2019-10-02 M 2,000 d 2,000 14,436.00 direct

SUGAR RONALD D - Director

2019-10-02 S 2,000 $193.58 d 14,436 14,436.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments